ATE345814T1 - Herstellung eines chimeren papillomavirus - Google Patents
Herstellung eines chimeren papillomavirusInfo
- Publication number
- ATE345814T1 ATE345814T1 AT01952419T AT01952419T ATE345814T1 AT E345814 T1 ATE345814 T1 AT E345814T1 AT 01952419 T AT01952419 T AT 01952419T AT 01952419 T AT01952419 T AT 01952419T AT E345814 T1 ATE345814 T1 AT E345814T1
- Authority
- AT
- Austria
- Prior art keywords
- chimeric
- preparation
- papilloma virus
- hpv
- virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20041—Use of virus, viral particle or viral elements as a vector
- C12N2710/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20041—Use of virus, viral particle or viral elements as a vector
- C12N2710/20044—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21655600P | 2000-07-07 | 2000-07-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE345814T1 true ATE345814T1 (de) | 2006-12-15 |
Family
ID=22807511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01952419T ATE345814T1 (de) | 2000-07-07 | 2001-07-03 | Herstellung eines chimeren papillomavirus |
Country Status (8)
Country | Link |
---|---|
US (1) | US6841157B2 (de) |
EP (1) | EP1309342B1 (de) |
JP (1) | JP2004502452A (de) |
AT (1) | ATE345814T1 (de) |
CA (1) | CA2415763A1 (de) |
DE (1) | DE60124725T2 (de) |
ES (1) | ES2275699T3 (de) |
WO (1) | WO2002004595A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010112533A1 (en) * | 2009-04-03 | 2010-10-07 | Deutsches Krebsforschungszentrum | Enhanced production of papillomavirus-like particles with a modified baculovirus expression system |
US20130149696A1 (en) * | 2010-06-02 | 2013-06-13 | European Molecular Biology Laboratory | High-throughput method for determining the presence of papillomavirus-neutralizing antibodies in a sample |
CN102285721B (zh) * | 2011-06-08 | 2012-11-21 | 广东恒兴饲料实业股份有限公司 | 降低对虾池塘氨氮和亚硝酸氮水平的发酵产品组合物及其制备方法 |
CN114716562B (zh) * | 2021-01-04 | 2023-11-10 | 中国医学科学院基础医学研究所 | 一种人***瘤病毒58型嵌合蛋白及其用途 |
CN117737311B (zh) * | 2024-02-20 | 2024-04-19 | 湖南派智生物科技有限公司 | 检测犬***瘤病毒的通用引物对、试剂、试剂盒及应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376542A (en) | 1992-04-27 | 1994-12-27 | Georgetown University | Method for producing immortalized cell lines using human papilluma virus genes |
US5618536A (en) * | 1992-09-03 | 1997-04-08 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric papillomavirus-like particles |
AUPN015794A0 (en) | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
EP0812358A1 (de) * | 1995-02-24 | 1997-12-17 | Cantab Pharmaceuticals Research Limited | Polypeptide verwendbar als immunotherapeutischen mitteln und verfahren zur bereitung von polypeptiden |
EP0922105B1 (de) * | 1996-07-17 | 2005-12-07 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Infektiöse pseudovirale papillomavirus partikel |
US5994115A (en) * | 1997-07-22 | 1999-11-30 | The Penn State Research Foundation | Artificial system for the production of infectious human papillomavirus |
CA2229955C (en) * | 1998-02-20 | 2003-12-09 | Medigene Gmbh | Papilloma virus capsomere vaccine formulations and methods of use |
WO2000039151A1 (en) * | 1998-12-23 | 2000-07-06 | Merck & Co., Inc. | Neutralizing assay using human papillomavirus virus-like particles |
US6495361B1 (en) * | 2000-07-21 | 2002-12-17 | University Of Arkansas | Method of producing infectious papillomavirus in placental cells |
-
2001
- 2001-07-03 EP EP01952419A patent/EP1309342B1/de not_active Expired - Lifetime
- 2001-07-03 WO PCT/US2001/021201 patent/WO2002004595A2/en active IP Right Grant
- 2001-07-03 AT AT01952419T patent/ATE345814T1/de not_active IP Right Cessation
- 2001-07-03 DE DE60124725T patent/DE60124725T2/de not_active Expired - Fee Related
- 2001-07-03 US US10/332,553 patent/US6841157B2/en not_active Expired - Fee Related
- 2001-07-03 CA CA002415763A patent/CA2415763A1/en not_active Abandoned
- 2001-07-03 ES ES01952419T patent/ES2275699T3/es not_active Expired - Lifetime
- 2001-07-03 JP JP2002509450A patent/JP2004502452A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ES2275699T3 (es) | 2007-06-16 |
DE60124725D1 (de) | 2007-01-04 |
CA2415763A1 (en) | 2002-01-17 |
EP1309342A4 (de) | 2005-01-26 |
JP2004502452A (ja) | 2004-01-29 |
US20040043471A1 (en) | 2004-03-04 |
WO2002004595A3 (en) | 2002-05-23 |
DE60124725T2 (de) | 2007-10-04 |
US6841157B2 (en) | 2005-01-11 |
EP1309342A2 (de) | 2003-05-14 |
EP1309342B1 (de) | 2006-11-22 |
WO2002004595A2 (en) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wieland et al. | Papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? | |
NO874750D0 (no) | Bestemte dna-sekvenser avledet fra en papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater. | |
UA85536C2 (en) | Viral antigens | |
EP1375652A3 (de) | Orale Zusammensetzung für HIV-Infizierte | |
DE50214416D1 (de) | Vermehrung von viren in zellkultur | |
Bonnez et al. | Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined immunodeficiency mouse | |
DE69104380D1 (de) | Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro-diagnose und zur herstellung einer immunogenenzusammensetzung. | |
HK1085378A1 (en) | Use of hpv16 and hpv18 as vaccine against one or more of oncogenic hpv type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 | |
HUP0303942A2 (hu) | Új vakcinakészítmények | |
WO2002004007A3 (en) | Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof | |
ATE345814T1 (de) | Herstellung eines chimeren papillomavirus | |
HK1070671A1 (en) | Cotton rat lung cells for virus culture | |
ATE380034T1 (de) | Neues verfahren zur herstellung von virus- ähnlichen partikeln des menschen-papillomavirus mit verbesserten eigenschaften | |
Madeley | Origins of electron microscopy and viral diagnosis. | |
AU5460900A (en) | Infectious cdna clone of gb virus b and uses thereof | |
DE69924262D1 (de) | Verfahren zur herstellung von durch hefe exprimierte hpv typs 6 und 16 kapsid-proteinen | |
CA2237224A1 (en) | Synthetic hpv11 virus-like particles | |
DE69924007D1 (de) | Neutralsierungs-assay, das humane papillomavirus-ähnliche partikel verwendet | |
Selvakumar et al. | T-cell response to cottontail rabbit papillomavirus structural proteins in infected rabbits | |
SI1572233T1 (sl) | Uporaba HPV16 in HPV18 kot cepivo proti enemu ali več onkogenih HPV tipa 31,33,35,39,45,51,52,56,58,59,66,68 | |
Uzelac-Keserović et al. | Virus isolation from the kidney, tumors and lymph nodes of patients with BEN | |
Sauer et al. | A New Transforming Papovavirus Isolated from Primate Cells | |
KR970059274A (ko) | 수두 바이러스의 대량 생산 방법 | |
CA2250714A1 (en) | Animal cells and processes for the replication of influenza viruses | |
RU2000120615A (ru) | Вещество kf-1040, способ его получения и штамм gliocladium sp., обладающий способностью его продуцировать |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |